Fig. 1
Beneficial effects of SGLT2 inhibitors, SNS, sympathetic nervous system; LDL-c, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol
Fig. 1 | Cardiovascular Diabetology
Beneficial effects of SGLT2 inhibitors, SNS, sympathetic nervous system; LDL-c, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol
Cardiovascular Diabetology